Search For "bharat biotech"
Updated : 5 months ago IST
New Delhi [India], April 20 (ANI): Finance Minister Nirmala Sitharaman has approved a total of Rs 4,567.50 crore as advance payment to Serum Institute of India (SII) and Bharat Biotech to ramp up vaccine production against coronavirus, sources told ANI.
New Delhi [India], April 16 (ANI): The current production capacity of indigenously developed Covaxin vaccine will be doubled by May-June 2021 and then increased nearly 6-7 fold by July-August 2021, the government announced on Friday as the country is witnessing a record surge in COVID-19 inf
Mumbai (Maharashtra) [India], April 16 (ANI): Chief Minister Uddhav Thackeray on Thursday thanked Prime Minister Narendra Modi for allowing Maharashtra-government owned Haffkine Institute to manufacture Bharat Biotech's Covaxin, on the basis of transfer of technology.
Jaipur (Rajasthan) [India], April 15 (ANI): 320 doses of Bharat Biotech's COVAXIN went missing from the cold storage of Hari Bux Kanwatia Government Hospital in Jaipur on Wednesday. An FIR has been registered in the Shastri Nagar police station as vaccines went missing.
Updated : 6 months ago IST
Kathmandu [Nepal], March 20 (ANI): Nepal has approved India's indigenously developed COVID-19 vaccine Covaxin for emergency use.
Port Louis [Mauritius], March 19 (ANI): In a unified attempt to free the world of coronavirus, India on Friday handed over to Mauritius a commercial supply of 200,000 doses of Covaxin vaccines under the 'Vaccine Maitri' initiative.
New Delhi [India], March 17 (ANI): Ambassadors of Paraguay and Costa Rica have hailed India's initiative to supply vaccines to other countries as part of efforts to fight the COVID-19 crisis and said they were looking forward to getting India-made vaccines.
New Delhi [India], March 17 (ANI): External Affairs Minister S Jaishankar on Wednesday said he was proud to have taken 'Covaxin' and recalled that questions were raised when the indigenous COVID-19 vaccine manufactured by Bharat Biotech came to the market earlier this year.
Updated : 6 months, 1 week ago IST
New Delhi [India], March 10 (ANI): The Subject expert committee (SEC) of Drugs Controller General of India (DCGI) on Wednesday recommended removing the "clinical trial mode" condition related to Bharat Biotech's Covaxin.
Updated : 6 months, 2 weeks ago IST
New Delhi [India], March 4 (ANI): Bharat Biotech and Serum Institute of India (SII), the country's leading COVID-19 vaccine manufacturers, on Thursday submitted to the Delhi High Court that adequate capacity of vaccines were available for judicial staff, advocates and judges as frontline wor
New Delhi [India], March 4 (ANI): Taking suo-motu cognisance of demand for inclusion of all associated with judicial functioning as frontline workers, the Delhi High Court on Wednesday issued notice to Secretary, Principal Secretary of Ministry of Health and Family Welfare, and the Governmen
New Delhi [India], March 3 (ANI): Phase three results of the COVAXIN, a vaccine against COVID-19 which has been developed by Indian Council of Medical Research (ICMR) in partnership with Bharat Biotech International Limited (BBIL), has shown an interim vaccine efficacy of 81 per cent in p